海洋链霉菌LC6中新安莎霉素类抗生素的发掘及相关生物合成研究

项目来源

国家自然科学基金(NSFC)

项目主持人

张娟利

项目受资助机构

中国人民解放军第四军医大学

项目编号

81602979

立项年度

2016

立项时间

未公开

项目级别

国家级

研究期限

未知 / 未知

受资助金额

17.30万元

学科

医学科学-药物学-天然药物化学

学科代码

H-H34-H3402

基金类别

青年科学基金项目

关键词

次级代谢产物 ; 基因簇 ; 生物合成 ; 安莎霉素 ; 抗生素 ; antibiotics ; ansamycin ; secondary metabolite ; gene cluster ; biosynthesis

参与者

丁莉坤;张迪;李帆;谢品;杨星;高晓红;王艳华

参与机构

中国人民解放军第四军医大学

项目标书摘要:由于抗生素的长期广泛应用或滥用,耐药菌的出现速度远快于新药的开发速度,新型抗生素的研发迫在眉睫。以抗结核药物利福霉素和抗肿瘤药物美登木素为代表的安莎霉素是一类活性显著的大环内酰胺类抗生素,具有极高的成药率和巨大的结构发掘空间。前期,我们从海洋链霉菌LC6中分离鉴定了一类新型二聚5酮安莎霉素juanlimycin。本项目拟在此基础上继续发掘LC6菌株中潜在的新安莎霉素,一方面利用基因组挖掘策略进一步激活juanlimycin生物合成基因簇,以期获得结构新颖的安莎类化合物;另一方面,开展激活产物及juanlimycin的生物合成研究,阐明其独特的生物合成机制,为利用组合生物合成和合成生物学手段对已知安莎类抗生素进行结构改良奠定基础。本项目的研究不仅可以为新抗生素的研究提供安莎类药物先导,而且有望建立一套简便有效的微生物天然产物发掘与生物合成研究方法,为后续微生物次级代谢潜力的深度发掘提供借鉴。

Application Abstract: As antibiotic widely used or abused for a long time,drug-resistant bacteria arised much faster than the process of developing novel antibiotics,there is an urgent need for new classes of antibiotics.Ansamycins are a family of macrolactam antibiotics with a huge space to explore and remarkable potential of druggability exemplified by the antituberculosis rifamycins and antitumor maytansinoids.Previously,we have isolated juanlimycins A and B,the first discovery of dimeric pentaketide ansamycin,from Streptomyces sp.LC6.Accordingly,in this proposal,we are planning to activate the cryptic ansamycin biosynthetic gene cluster by genome mining strategy to obtain a novel monomeric pentaketide ansamycin and juanlimycin derivatives.In addition,we will also carry out the biosynthetic studies on these novel pentaketide ansamycin and clarify its unique biosynthetic mechanism,facilitating to transform known ansamycin antibiotics by combinatorial biosynthesis and synthetic biology.The outcomes of this project will not only provides new leads for drug discovery,but also will establish an efficient and simple method to access the new natural products and the biosynthetic studies,which will set the foundation for valuable experience for genome mining of the other biosynthetic potential of microbes.

项目受资助省

陕西省

项目结题报告(全文)

由于抗生素的长期广泛应用或滥用,耐药菌的出现速度远快于新药的开发速度,新型抗生素的研发迫在眉睫。以抗结核药物利福霉素和抗肿瘤药物美登木素为代表的安莎霉素是一类活性显著的大环内酰胺类抗生素,具有极高的成药率和巨大的结构发掘空间。前期,课题组通过PCR筛选获得了多株具有安莎霉素生产潜力的链霉菌,测序结果证实其微生物基因组上分别含有不同类型的安莎基因簇,但通过对其野生型菌株发酵产物进行分离,并未得到目标安莎霉素。基于此,我们通过对其安莎基因簇进行生物信息学分析、利用正调控基因过表达和基因敲除等策略尝试激活目标安莎基因簇,并从两株链霉菌突变菌株中成功分离得到了JL-1、seco-neoansamycins等结构新颖的安莎类化合物,最终结合新安莎的结构初步预测了其生物合成机制,为利用组合生物合成和合成生物学手段对已知安莎类抗生素进行结构改良奠定基础。此外,以抑菌活性为导向,从3株野生型链霉菌中分离鉴定了14个化合物,其中化合物monactin、dinactin、trinactin对多株临床分离的MRSA菌株都具有强的抑制活性,且dinactin和trinactin均表现出强于阳性对照品万古霉素的抗MRSA作用,分子对接结果进一步证实该类化合物与抗MRSA靶蛋白PBP2a均具有强的结合活性,因此有望开发为新型抗MRSA候选药物。综上,本项目的研究不仅可为新抗生素的研究提供药物先导,而且有望建立一套简便有效的微生物天然产物发掘与生物合成研究方法,为后续微生物次级代谢潜力的深度发掘提供借鉴。

  • 排序方式:
  • 2
  • /
  • 1.毛钩藤碱对Aβ淀粉样纤维化的抑制和降解作用

    • 关键词:
    • 毛钩藤碱;阿尔茨海默病;β-淀粉样蛋白;纤维化;抑制;降解
    • 张迪;张娟利;文爱东;王婧雯
    • 2025年
    • 期刊

    目的 探讨毛钩藤碱(hirsutine,HS)对β-淀粉样蛋白(Aβ)纤维化的影响。方法 体外孵育构建Aβ1-42淀粉样纤维化模型,硫黄素-T(ThT)染色分析Aβ1-42纤维化动力学曲线,透射电镜(TEM)、刚果红(CR)染色和圆二色谱(CD)观察其形态结构变化,8-苯胺-1-萘磺酸(ANS)染色检测疏水区域暴露,MTT、溶血和DCFH-DA染色实验评估Aβ1-42细胞毒性和细胞内ROS含量,分子对接实验分析HS与Aβ1-42相互作用。结果 HS可明显减弱ThT荧光强度(P1-42干预的SH-SY5Y细胞活性(P<0.05,P<0.01),降低溶血率(P&...

    ...
  • 2.管花苷B抑制Aβ淀粉样纤维化并降低其细胞毒性的研究

    • 关键词:
    • 管花苷B;阿尔茨海默症;β-淀粉样蛋白;纤维化;抑制作用
    • 张迪;张娟利;文爱东;王婧雯
    • 《药学学报》
    • 2024年
    • 期刊

    本文旨在探讨管花苷B (tubuloside B, Tub B) 对β-淀粉样蛋白 (amyloid β-protein, Aβ) 纤维化的抑制作用及潜在作用机制。采用体外孵育Aβ1-42建立蛋白质淀粉样纤维化模型, 利用硫黄素-T (thioflavin T, ThT)、刚果红 (Congo red, CR)、8-苯胺-1-萘磺酸 (8-anilino-1-naphthalene sulfonic acid, ANS) 染色和透射电子显微镜 (transmission electron microscope, TEM) 考察Tub B对Aβ1-42纤维形成的抑制作用; 圆二色谱 (circular dichroism, CD) 分析Tub B对Aβ1-42二级结构的影响; 3-(4,5-二甲基-2-噻唑)-2,5-二苯基溴化四氮唑噻唑蓝 [3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide, MTT] 和红细胞溶血实验研究Tub B对Aβ1-42诱导的细胞毒性的抑制作用; 2',7'-二氯二氢荧光素二乙酸酯 (2',7'-dichlorofluorescin diacetate, DCFH-DA) 染色检测Tub B对Aβ1-42诱导的细胞内活性氧 (reactive oxygen species, ROS) 含量的影响; 以及利用分子对接实验研究Tub B与Aβ1-42分子相互作用。结果显示, Tub B对Aβ1-42淀粉样纤维形成具有一定抑制作用, 可降低Aβ1-42二级结构中α-螺旋结构向β-折叠结构的转化, 减少疏水区域暴露, 减弱Aβ1-42引起的细胞毒性和红细胞溶血性, 降低细胞损伤。综上所述, Tub B能够抑制蛋白质淀粉样纤维形成, 且这种抑制作用可能与其抗氧化活性及与蛋白质分子间的氢键和疏水作用力有关。本研究的动物实验经空军军医大学动物实验伦理委员会批准 (批准号: 20190051)。

    ...
  • 3.Luteoloside inhibits Aβ1-42 fibrillogenesis, disintegrates preformed fibrils, and alleviates amyloid-induced cytotoxicity

    • 关键词:
    • Alzheimer's disease; Amyloid fibril; Luteoloside; Inhibition;Disaggregation; Cytotoxicity;BETA-PROTEIN FIBRILLATION; HUMAN SERUM-ALBUMIN; ALZHEIMERS-DISEASE;OXIDATIVE STRESS; THERAPEUTIC INTERVENTIONS; LONICERA-JAPONICA;ALPHA-SYNUCLEIN; BOVINE INSULIN; AGGREGATION; PEPTIDE
    • Zhang, Di;Zhang, Juanli;Ma, Zhongying;Wu, Qianwen;Liu, Meiyou;Fan, Tingting;Ding, Likun;Ren, Danjun;Wen, Aidong;Wang, Jingwen
    • 《BIOPHYSICAL CHEMISTRY》
    • 2024年
    • 306卷
    • 期刊

    Abnormal aggregation and fibrillogenesis of amyloid-beta protein (A beta) can cause Alzheimer's disease (AD). Thus, the discovery of effective drugs that inhibit A beta fibrillogenesis in the brain is crucial for the treatment of AD. Luteoloside, as one of the polyphenolic compounds, is found to have a certain therapeutic effect on nervous system diseases. However, it remains unknown whether luteoloside is a potential drug for treating AD by modulating A beta aggregation pathway. In this study, we performed diverse biophysical and biochemical methods to explore the inhibition of luteoloside on A beta 1-42 which is linked to AD. The results demonstrated that luteoloside efficiently prevented amyloid oligomerization and cross-beta-sheet formation, reduced the rate of amyloid growth and the length of amyloid fibrils in a dose-dependent manner. Moreover, luteoloside was able to influence aggregation and conformation of A beta 1-42 during different fiber-forming phases, and it could disintegrate already preformed fibrils of A beta 1-42 and convert them into nontoxic aggregates. Furthermore, luteoloside protected cells from amyloid-induced cytotoxicity and hemolysis, and attenuated the level of reactive oxygen species (ROS). The molecular docking study showed that luteoloside interacted with A beta 1-42 mainly via Conventional Hydrogen Bond, Carbon Hydrogen Bond, Pi-Pi T-shaped, Pi-Alkyl and Pi-Anion, thereby possibly preventing it from forming the aggregates. These observations indicate that luteoloside, a natural anti-oxidant molecule, may be applicable as an effective inhibitor of A beta, and promote further exploration of the therapeutic strategy against AD.

    ...
  • 4.Proansamycin B derivatives from the post-PKS modification gene deletion mutant of Amycolatopsis mediterranei S699.

    • Ma, Xinyu;Ye, Feng;Zhang, Xiaochun;Li, Zhan;Ding, Yanjiao;Lu, Chunhua;Shen, Yuemao
    • 《The Journal of antibiotics》
    • 2024年
    • 期刊

    Ten new proansamycin B congeners (1-10) together with one known (11) were isolated and characterized on the basis of 1D and 2D NMR spectroscopic and HRESIMS data from the Amycolatopsis mediterranei S699 DeltaPM::rifR+rif-orf19 mutant. Compounds 8 and 9 featured with six-membered ring and five-membered ring hemiketal, respectively. Compounds 1, 2, and 9 displayed antibacterial activity against MRSA (methicillin-resistant Staphylococcus aureus), with the MIC (minimal inhibitory concentration) values of 64, 8, and 128g/mL, respectively. Compound 1 showed significant cytotoxicity against MDA-MB-231, HepG2 and Panc-1 cell lines with IC50 (half maximal inhibitory concentration) values of 2.3±0.2, 2.5±0.3 and 3.8±0.5muM, respectively. © 2024. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.

    ...
  • 5.毛蕊花糖苷对中波紫外线所致小鼠皮肤损伤的保护作用研究

    • 关键词:
    • 毛蕊花糖苷;UVB照射;皮肤损伤;DNA损伤;磷酸化的H2AX组蛋白;环丁烷嘧啶二聚体;6-4光产物;8-羟基-2-脱氧鸟嘌呤核苷;小鼠
    • 张迪;张娟利;马忠英
    • 《中药新药与临床药理》
    • 2023年
    • 1期
    • 期刊

    目的 研究毛蕊花糖苷对中波紫外线(UVB)照射所致小鼠皮肤损伤的保护作用。方法 将Balb/c小鼠随机分为正常对照组、UVB模型组、基质+UVB组、1%毛蕊花糖苷+UVB组、5%毛蕊花糖苷+UVB组、5%维生素E+UVB组,每组10只。除正常对照组外,其余4组

    ...
  • 6.剑叶龙血树内生链霉菌S009中抗菌活性成分的研究

    • 关键词:
    • 剑叶龙血树;内生链霉菌;结构鉴定;大环四重内酯类成分;耐甲氧西林金黄色葡萄球菌
    • 宋薇;许小蓉;葛洁;李慧玲;文爱东;王婧雯;张晓梅;张娟利
    • 《中国现代应用药学》
    • 2022年
    • 20期
    • 期刊

    目的对剑叶龙血树内生链霉菌S009中抗菌活性成分进行研究。方法采用Sephadex LH-20、反相柱色谱、硅胶柱层析及HPLC对S009菌株的发酵产物进行分离纯化,并通过MS、NMR等波谱技术鉴定其结构。结果从S009菌株中分离并鉴定了4个大环四重内

    ...
  • 7.Rifamycin W Analogues from Amycolatopsis mediterranei S699 Delta rif-orf5 Strain

    • 关键词:
    • Amycolatopsis mediterranei S699; rifamycin W; polyketide backbonerearrangement; oxidative cleavage;B BIOSYNTHESIS; GENE-CLUSTER; IDENTIFICATION; ANSAMYCINS; MUTANT;OVEREXPRESSION; RESISTANCE; RIFAMPICIN; DIVERSITY; INCREASES
    • Shi, Yanrong;Ye, Feng;Song, Yuliang;Zhang, Xiaochun;Lu, Chunhua;Shen, Yuemao
    • 《BIOMOLECULES》
    • 2021年
    • 11卷
    • 7期
    • 期刊

    Rifamycin W, the most predominant intermediate in the biosynthesis of rifamycin, needs to undergo polyketide backbone rearrangement to produce rifamycin B via an oxidative cleavage of the C-12/C-29 double bond. However, the mechanism of this putative oxidative cleavage has not been characterized yet. Rif-Orf5 (a putative cytochrome P450 monooxygenase) was proposed to be involved in the cleavage of this olefinic moiety of rifamycin W. In this study, the mutant strain Amycolatopsis mediterranei S699 Delta rif-orf5 was constructed by in-frame deleting the rif-orf5 gene to afford thirteen rifamycin W congeners (1-13) including seven new ones (1-7). Their structures were elucidated by extensive analysis of 1D and 2D NMR spectroscopic data and high-resolution ESI mass spectra. Presumably, compounds 1-4 were derivatized from rifamycin W via C-5/C-11 retro-Claisen cleavage, and compounds 1-3, 9 and 10 featured a hemiacetal. Compounds 5-7 and 11 showed oxygenations at various sites of the ansa chain. In addition, compounds 1-3 exhibited antibacterial activity against Staphylococcus aureus with minimal inhibitory concentration (MIC) values of 5, 40 and 0.5 mu g/mL, respectively. Compounds 1 and 3 showed modest antiproliferative activity against HeLa and Caco-2 cells with half maximal inhibitory concentration (IC50) values of about 50 mu M.

    ...
  • 8.基于网络药理学探讨丹参-丹皮配伍抗脑缺血损伤的作用机制

    • 关键词:
    • 网络药理学;分子对接;丹参-丹皮;脑卒中;作用机制
    • 张娟利;李骅;王文军;黄少杰;马阳;丁一;文爱东
    • 《天然产物研究与开发》
    • 2021年
    • 01期
    • 期刊

    本文旨在通过网络药理学和分子对接方法探讨丹参-丹皮活性成分治疗脑卒中的潜在分子机制。首先基于中药系统药理学分析平台筛选丹参、丹皮的活性成分及其作用靶点,利用CTD、TTD和GeneCards数据库收集脑卒中相关靶点。然后将药物和疾病靶点取交集,借助STRING数据库获取靶点间相互作用关系,利用R语言的ClusterProfiler包对其进行生物功能和通路富集分析。最后,通过Cytoscape软件构建蛋白质-蛋白质相互作用和成分-靶点-通路网络图,并利用AutoDock Vina软件对网络中的关键靶点及对应成分进行分子对接验证。结果显示丹参-丹皮成分作用于脑卒中的靶点67个,GO分析显示其主要参与脂多糖应答,细菌来源的分子反应,氧化应激等生物学过程。KEGG通路富集共得到149条通路(P<0.05),主要涉及AGE-RAGE信号通路、IL-17信号通路、TNF信号通路等。分子对接结果显示,筛选的主要活性成分与其对应靶蛋白均具有较好的结合活性。综上,本研究通过网络药理学预测了丹参-丹皮治疗脑卒中可能的药效物质基础及其作用机制,为进一步挖掘其药效成分和临床扩大使用范围提供科学依据。

    ...
  • 9.8-Deoxy-Rifamycin Derivatives from Amycolatopsis mediterranei S699 Delta rifT Strain

    • 关键词:
    • rifamycin; Amycolatopsis mediterranei S699; proansamycin X;dehydrogenation; N-glycoside rifamycin;RIFAMYCIN-B BIOSYNTHESIS; TYPE-3 SECRETION SYSTEM; ANSAMYCINS;IDENTIFICATION; RIFAMPICIN; OVEREXPRESSION; KANOSAMINE; RESISTANCE;INHIBITOR; DIVERSITY
    • Ye, Feng;Shi, Yanrong;Zhao, Shengliang;Li, Zhiying;Wang, Haoxin;Lu, Chunhua;Shen, Yuemao
    • 《BIOMOLECULES》
    • 2020年
    • 10卷
    • 9期
    • 期刊

    Proansamycin X, a hypothetical earliest macrocyclic precursor in the biosynthesis of rifamycin, had never been isolated and identified. According to bioinformatics analysis, it was proposed that RifT (a putative NADH-dependent dehydrogenase) may be a candidate target responsible for the dehydrogenation of proansamycin X. In this study, the mutant strain Amycolatopsis mediterranei S699 Delta rifT was constructed by deleting the rifT gene. From this strain, eleven 8-deoxy-rifamycin derivatives (1-11) and seven known analogues (12-18) were isolated. Their structures were elucidated by extensive analysis of 1D and 2D NMR spectroscopic data and high-resolution ESI mass spectra. Compound 1 is a novel amide N-glycoside of seco-rifamycin. Compounds 2 and 3 feature conserved 11,12-seco-rifamycin W skeleton. The diverse post-modifications in the polyketide chain led to the production of 4-11. Compounds 2, 3, 5, 6, 13 and 15 exhibited antibacterial activity against Staphylococcus aureus (MIC (minimal inhibitory concentration) values of 10, 20, 20, 20, 40 and 20 mu g/mL, respectively). Compounds 14, 15, 16, 17 and 18 showed potent antiproliferative activity against KG1 cells with IC50 (half maximal inhibitory concentration) values of 14.91, 44.78, 2.16, 18.67 and 8.07 mu M, respectively.

    ...
  • 10.松果菊苷防晒乳膏剂的制备工艺与质量评价

    • 关键词:
    • 松果菊苷;乳膏剂;制备工艺;质量评价
    • 张迪;张娟利;宋薇;丁莉坤;马忠英;文爱东
    • 《中南药学》
    • 2020年
    • 04期
    • 期刊

    目的研究松果菊苷防晒乳膏剂的制备工艺,并对其质量进行评价。方法通过正交试验对松果菊苷防晒乳膏剂基质处方进行优化,优选出最佳处方;通过紫外扫描法建立质量评价标准。结果优选出松果菊苷防晒乳膏剂的最佳处方为松果菊苷5%、硬脂酸10%、单硬脂酸甘油酯5%、液状石蜡5%、白凡士林10%、三乙醇胺4%、氮酮3%、尼泊金乙酯0.1%。按照该处方制备的乳膏剂在最大吸收波长334 nm处的吸光度值相对稳定。结论松果菊苷防晒乳膏剂的制备工艺简单,所得制剂性质稳定,质量可控,测定方法简便、快捷、准确,为后期进一步研究和应用奠定了基础。

    ...
  • 排序方式:
  • 2
  • /